Active Not Recruiting PHASE1 INTERVENTIONAL 3-arm NCT03241706

Liver Glycogen and Hypoglycemia in Humans

Effect of Liver Glycogen Content on Hypoglycemic Counterregulation

Sponsor: Jason Winnick

Interventions Dextrose solution Glucagon High Fructose Insulin Low Fructose Saline Somatostatin

Updated 8 times since 2017 Last updated: Jul 23, 2025 Started: Aug 2, 2018 Primary completion: May 31, 2028 Completion: May 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03241706, this PHASE1 trial focuses on Hypoglycemia; Iatrogenic and remains ongoing. Sponsored by Jason Winnick, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Aug 2025 — Present [monthly]

Active Not Recruiting PHASE1
Sep 2024 — Aug 2025 [monthly]

Active Not Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE1
Mar 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE1

Status: Unknown Status → Active Not Recruiting
Jul 2022 — Mar 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jan 2021 — Jul 2022 [monthly]

Recruiting PHASE1
Jun 2020 — Jan 2021 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Sep 2017 — Jun 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jason Winnick

Data source: University of Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States